A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1/2 Trial of ADI-270 in ccRCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
- Status
- RECRUITING
- Phase
- PHASE1
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
- Status
- RECRUITING
- Phase
- PHASE2
Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
- Status
- RECRUITING
- Phase
- PHASE1
Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201
- Status
- WITHDRAWN
- Phase
- PHASE1
Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
Ma-Spore ALL 2020 Study
- Status
- RECRUITING
- Phase
- PHASE2
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2